Kusumgar Limited is heading to the primary market with a ₹650 crore IPO opening on July 8, 2026. The company manufactures high-performance engineered fabrics for aerospace, defence, automotive, and outdoor segments — a niche with strong tailwinds from India's defence push. But declining FY26 financials and a 100% promoter exit structure raise important questions. Here is our complete analysis.

Kusumgar IPO — Key Details
- IPO Open Date: July 8, 2026
- IPO Close Date: July 10, 2026
- Price Band: ₹398 – ₹419 per share
- Issue Size: ₹650 crore — 100% Offer for Sale (no fresh issue)
- Allotment Date: July 13, 2026
- Listing Date: July 15, 2026 (NSE & BSE)
- GMP Today: ₹130–₹135 (estimated listing price ₹549–₹554, ~31% premium)
- Lot Size: TBA | Face Value: ₹10
About Kusumgar Limited
Kusumgar manufactures woven, coated, and laminated synthetic fabrics using polyamides, polyester filaments, and polyurethane chemistry. Its products serve four key end markets: aerospace and defence, industrial and automotive, outdoor and lifestyle, and technical textiles.
The company supplies to clients in India and internationally. The aerospace and defence vertical benefits directly from India's rapidly expanding defence production push under the PLI scheme and rising indigenisation requirements, making Kusumgar a play on India's defence manufacturing story.
Financial Performance — The Concern
- Revenue FY26: ₹692 crore (down 11.2% from ₹779 crore in FY25)
- Net Profit FY26: ₹98.2 crore (down 12.3% from ₹112 crore in FY25)
This is the key red flag. Both revenue and profit declined in FY26. For a company coming to market at a premium valuation, declining financials in the most recent year warrant scrutiny. Investors should read the company's explanation for the decline — whether it is cyclical (sector-wide slowdown) or structural (market share loss, pricing pressure).
GMP — What the Grey Market Is Saying
As of July 3, 2026, Kusumgar IPO GMP stands at ₹130–₹135, implying an estimated listing price of ₹549–₹554 against the upper price band of ₹419. This represents a potential listing gain of ~31%. The GMP peaked at ₹135 on July 3.
A GMP of 31% is strong and reflects positive grey market sentiment around the defence fabric theme. However, given the declining financials, this GMP appears to be pricing in a sector narrative rather than recent company performance. GMP is informal and can shift sharply — always check IPOLyst for the latest GMP before applying.
Key Risks
- 100% OFS — promoters are fully exiting. Zero fresh capital flows into the company.
- Revenue and profit both declined in FY26 — a concerning trend for a company seeking a premium valuation.
- Highly dependent on a few end markets (aerospace, defence) — sector slowdowns can hurt disproportionately.
- Polyurethane and polyester raw material costs are volatile and impact margins.
- GMP-driven euphoria around defence names can fade quickly if subscription numbers disappoint.
Strengths
- Niche manufacturer in high-barrier technical textiles — not easy to replicate.
- Direct beneficiary of India's defence indigenisation push — strong policy tailwind.
- International client base providing revenue diversification.
- Established relationships with government and PSU defence buyers.
Valuation Assessment
At a price band of ₹419 and FY26 earnings of ₹98.2 crore, the P/E at listing works out to approximately 35–38x. For a company with declining revenue and profit in its most recent fiscal year, this is a stretched valuation. Investors are essentially paying for the future recovery and the defence sector story — not the current financial trajectory.
Our Verdict — Apply or Avoid?
Kusumgar is a company with a genuinely interesting niche in defence fabrics — a sector that is structurally growing in India. However, the FY26 financial decline combined with a 100% OFS structure (promoter exit) and premium valuation makes this a high-risk, high-reward bet.
Conservative investors should avoid or apply with caution. The strong GMP (₹130) suggests grey market participants are bullish on the defence theme, but grey market sentiment has been wrong before on companies with declining earnings.
Risk-tolerant investors who believe FY26 was a one-year blip and that defence sector demand will recover can apply — but set realistic expectations and monitor subscription data closely, especially QIB participation on Day 2.
Track live GMP, subscription, and allotment status on IPOLyst throughout the IPO window.
Disclaimer: This review is for informational purposes only. IPOLyst is not a SEBI-registered investment advisor. Please read the DRHP and consult a financial advisor before investing.